FIGURE 3.

A, Tendon diameter clinically measured in treated group and control group at each time point, expressed in millimeters (mm). B, Tendon diameter (mm) echographically measured in treated group and control group at each time point. C, Tendon hardness (%) at elastosonographical evaluation in both groups at each time point. Red and blue triangles indicate the single measurements scattered in groups; boxes indicate mean values; bars indicate standard errors; Ti: initial healthy tendon condition immediately before induction of experimental tendon lesion; T0: 14 days after the induction of tendon lesion (treated group underwent therapy with stromal vascular fraction); T1: 4 weeks after T0; T2: end of the study, 8 weeks after T0. P‐values, ns: not significant; *P < .05; **P < .01; ***P < .001; ****P < .0001; # indicates the only significant difference (P < .0342) found between groups